First Page | Meta Content | |
---|---|---|
Contains Nonbinding Recommendations Draft Guidance on Ibrutinib This draft guidance, once finalized, will represent the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or coOpen Document |